Test Strips Market by Product (Urinary Test Strips, Diabetes Test strips), by End-user (Hospitals, Diagnostic Centres, Home Care): Competitive Market Share & Forecast, 2021 – 2027

ID: VPR/HC/271 Publishing Year: February 2021 Pages: 108 Format:   


Test Strip is an important diagnostic tool in diagnostics centres, which helps in achieving accurate and rapid diagnosis of various essential disorders such as kidney disease, diabetes examination, ophthalmic disease and others. Test Strips are key components in blood glucose and urine test. Test Strips helps to monitor and control glucose level of a diabetic patient. Furthermore, pre-diabetic and diabetic patients monitor their blood glucose level on a regular basis without visiting a clinic or diagnostic centres by using Test Strips. The Test Strips are based on various technologies such as electrochemical and photometric. Most Test Strips are based on electrical-chemical technology.

Rising diabetic population, rising incidences of urinary tract infection (UTI) and numerous technological innovations in Test Strips Market are prime factors driving the Growth of Test Strips Market. In addition, rising prevalence of kidney diseases due to rising alcohol consumption will drive Market Growth for Test Strips Significantly. However, people tend to neglect regular health check-ups in underdeveloped regions of the world, owing to an increasing number of undiagnosed patients which restricts the growth of market. Conversely, increase in government's support in various healthcare sectors Test Strip Market is expected to grow in future.

Segment Insight:

The Test Strips Market is segmented based on product, end-user and region. Based on product, it is classified into urinary test strips, diabetes test strips. Based on end-user, it is divided into hospitals, diagnostic centres, home care.

By Product Insight:

The Test strips market is segmented by product into urinary test strips, diabetes test strips.

 

By End-user Insight:

The Test Strips Market is segmented by end-user into into hospitals, diagnostic centres, home care.

 

Major Key Players of Global Test Strips Market:

The report provides a comprehensive analysis of the Key Players operating in the Global Test Strips Market, such as Abbott Laboratories, Bayer, Roche Diagnostics, Lifescan, Inc., Ascensia Diabetes Care Holdings Ag, B. Braun Melsungen AG, Arkray Inc, Henry Schein, Chiltern Medicare Ltd, Siemens Healthcare. Most of the key players in Test Strips are focusing on business expansion to gain a higher revenue share through the adoption of strategies, such as mergers and acquisitions and new product development.

Test Strips Market Key Segments:

By Product

  • Urinary test strips
  • Diabetes test strips

By End-user

  • Hospitals
  • Diagnostic centres
  • Home care

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Argentina
    • Turkey
    • South Africa
    • Rest of LAMEA


Frequently Asked Questions
Abbott Laboratories, Bayer, Roche Diagnostics, Lifescan, Inc., Ascensia Diabetes Care Holdings Ag, B. Braun Melsungen AG, Arkray Inc, Henry Schein, Chiltern Medicare Ltd, Siemens Healthcare.
Rising diabetic population, rising incidences of urinary tract infection (UTI) and numerous technological innovations in Test Strips Market are prime factors driving the growth of test strips market. In addition, rising prevalence of kidney diseases due to rising alcohol consumption will Drive Market Growth for Test Strips Significantly.

TABLE OF CONTENTS:

CHAPTER 1 MARKET INTRODUCTION

1.1. REPORT OVERVIEW

1.2. SCOPE OF THE STUDY

1.3. PRIMARY MARKET SEGMENTS

1.4. RESEARCH METHODOLOGY

CHAPTER 2 EXECUTIVE SUMMARY

2.1. C-LEVEL EXECUTIVE’S OVERVIEW AND PERSPECTIVES

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE

3.2. PRINCIPAL FINDINGS

3.2.1. Key investment pockets

3.2.2. Leading winning strategies

  3.2.3 Key Player Positioning

3.3. PORTERS FIVE FORCES OF COMPETITIVE ANALYSIS

 3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.2. Restraints

3.4.3. Opportunities

3.4.4. Impact Analysis

3.5. IMPACT OF COVID-19 ON THIS MARKET

CHAPTER 4 TEST STRIPS MARKET, BY PRODUCT

4.1. SYNOPSIS

4.1.1. Market size and forecast

4.2. URINARY TEST STRIPS

4.2.1. Key market trends

4.2.2. Growth factors and opportunities

4.2.3. Market size and forecast

4.3. DIABETES TEST STRIPS

4.3.1. Key market trends

4.3.2. Growth factors and opportunities

4.3.3. Market size and forecast

CHAPTER 5 TEST STRIPS MARKET, BY END USER

5.1. SYNOPSIS

5.1.1. Market size and forecast

5.2. HOSPITALS

5.2.1. Market size and forecast

5.3. DIAGNOSTICS CENTRES

5.3.1. Market size and forecast

5.4. HOME CARE

5.3.1. Market size and forecast

CHAPTER 6 TEST SRIPS MARKET, BY REGION

6.1 SYNOPSIS

6.2 North America

6.2.1 Key market trends

6.2.2 Competitive scenario

6.2.3 Key growth factors and opportunities

6.2.4 Market size and forecast

6.3 Europe

6.3.1 Key market trends

6.3.2 Competitive scenario

6.3.3 Key growth factors and opportunities

6.3.4 Market size and forecast

6.4 Asia Pacific

6.4.1 Key market trends

6.4.2 Competitive scenario

6.4.3 Key growth factors and opportunities

6.4.4 Market size and forecast

6.5 LAMEA

6.5.1 Key market trends

6.5.2 Key growth factors and opportunities

6.5.3 Market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1. ABBOTT LABORATORIES

7.1.1. Company overview

7.1.2. Company snapshot

7.1.3. Product portfolio

7.1.4. Business performance

7.1.5. Key strategic moves and developments

7.2. BAYER

7.2.1. Company overview

7.2.2. Company snapshot

7.2.3. Operating business segments

7.2.4. Product portfolio

7.2.5. Business performance

7.2.6. Key strategic moves and developments

7.3. ROCHE DIAGNOSTICS

7.3.1. Company overview

7.3.2. Company snapshot

7.3.3. Operating business segments

7.3.4. Product portfolio

7.3.5. Business performance

7.3.6. Key strategic moves and developments

7.4. LIFESCAN, INC.

7.4.1. Company overview

7.4.2. Company snapshot

7.4.3. Operating business segments

7.4.4. Product portfolio

7.4.5. Business performance

7.4.6. Key strategic moves and developments

7.5. ASCENSIA DIABETES CARE HOLDINGS AG

7.5.1. Company overview

7.5.2. Company snapshot

7.5.3. Operating business segments

7.5.4. Product portfolio

7.5.5. Business performance

7.5.6. Key strategic moves and developments

7.6. B. BRAUN MELSUNGEN AG

7.6.1. Company overview

7.6.2. Company Snapshot

7.6.3. Operating business segments

7.6.4. Product portfolio

7.6.5. Business performance

7.6.6. Key strategic moves and developments

7.7. ARKRAY INC

7.7.1. Company overview

7.7.2. Company snapshot

7.7.3. Operating business segments

7.7.4. Product portfolio

7.7.5. Business performance

7.7.6. Key strategic moves and developments

7.8. HENRY SCHEIN

7.8.1. Company overview

7.8.2. Company snapshot

7.8.3. Operating business segments

7.8.4. Product portfolio

7.8.5. Business performance

7.8.6. Key strategic moves and developments

7.9. CHILTERN MEDICARE LTD

7.9.1. Company overview

7.9.2. Company snapshot

7.9.3. Operating business segments

7.9.4. Product portfolio

7.9.5. Business performance

7.9.6. Key strategic moves and developments

7.10. SIEMENS HEALTHCARE

7.10.1. Company overview

7.10.2. Company snapshot

7.10.3. Product portfolio

7.10.4. Key strategic moves and developments


PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-935-919-4956 )

CONTACT EMAIL
[email protected]
PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-935-919-4956 )

CONTACT EMAIL
[email protected]